ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,637,000 | +38.8% | 1,590,686 | 0.0% | 0.02% | -4.8% |
| Q1 2020 | $3,340,000 | -55.4% | 1,590,686 | -30.5% | 0.02% | -47.5% |
| Q4 2019 | $7,483,000 | +157.1% | 2,288,235 | +77.6% | 0.04% | +100.0% |
| Q3 2019 | $2,911,000 | -52.7% | 1,288,235 | 0.0% | 0.02% | -52.4% |
| Q2 2019 | $6,158,000 | -35.0% | 1,288,235 | 0.0% | 0.04% | -31.1% |
| Q1 2019 | $9,481,000 | -36.9% | 1,288,235 | -38.7% | 0.06% | -50.4% |
| Q4 2018 | $15,017,000 | -46.3% | 2,103,164 | -3.7% | 0.12% | -33.2% |
| Q3 2018 | $27,960,000 | -20.0% | 2,184,364 | 0.0% | 0.18% | -30.0% |
| Q2 2018 | $34,950,000 | +11.5% | 2,184,364 | 0.0% | 0.26% | -1.1% |
| Q1 2018 | $31,346,000 | -0.3% | 2,184,364 | +10.1% | 0.27% | -2.6% |
| Q4 2017 | $31,452,000 | +9.5% | 1,984,364 | +17.8% | 0.27% | +17.2% |
| Q3 2017 | $28,718,000 | +166.4% | 1,684,364 | 0.0% | 0.23% | +147.9% |
| Q2 2017 | $10,780,000 | +28.0% | 1,684,364 | 0.0% | 0.09% | +36.2% |
| Q1 2017 | $8,422,000 | +3.1% | 1,684,364 | 0.0% | 0.07% | -13.8% |
| Q4 2016 | $8,169,000 | +1239.2% | 1,684,364 | +1556.5% | 0.08% | +1233.3% |
| Q3 2016 | $610,000 | – | 101,680 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,859,767 | $4,490,000 | 3.06% |
| Cedar Brook Financial Partners, LLC | 55,000 | $86,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8,287,995 | $13,012,000 | 0.03% |
| Platform Technology Partners | 27,706 | $43,000 | 0.02% |
| Virtu Financial LLC | 118,030 | $185,000 | 0.02% |
| WS MANAGEMENT LLLP | 97,173 | $153,000 | 0.02% |
| WEXFORD CAPITAL LP | 26,597 | $42,000 | 0.01% |
| MEITAV INVESTMENT HOUSE LTD | 92,000 | $144,000 | 0.01% |
| CAMBRIDGE TRUST CO | 65,414 | $103,000 | 0.01% |
| QS Investors, LLC | 215,000 | $338,000 | 0.00% |